DONOR MHC CLASS II+ CELLS ARE NEEDED TO PREVENT CHRONIC REJECTION IN ANIMALS TREATED WITH CTLA4IG

Citation
C. Magee et al., DONOR MHC CLASS II+ CELLS ARE NEEDED TO PREVENT CHRONIC REJECTION IN ANIMALS TREATED WITH CTLA4IG, Journal of the American Society of Nephrology, 8, 1997, pp. 3080-3080
Citations number
NO
Categorie Soggetti
Urology & Nephrology
ISSN journal
10466673
Volume
8
Year of publication
1997
Supplement
S
Pages
3080 - 3080
Database
ISI
SICI code
1046-6673(1997)8:<3080:DMCICA>2.0.ZU;2-Q